A contact as intimate as sex reasonably leads to transfer of diseases if one is infected. No matter how you practice safe sex, if you are sexually active, there is always that danger of acquiring a sexually transmitted disease (STD). Regular visits to the right doctor is an absolute must.
A new study announces a vaccine that can possibly prevent the STD, chlamydia. According to Shape, a research team from McMaster University has successfully made the first vaccine against the STD or at least showed encouraging trial results.
The most common type of the STD, chlamydia is prevented by an antigen called BD584. Using this line of defense, the researchers were able to come out with a vaccine that can prevent the STD, chlamydia (via Shape).
The vaccine was injected to people with chlamydia on their noses. It resulted to positive effects, reducing the spreading of the STD by 95 percent and the blockage of fluids on women's fallopian tubes by 87 percent.
According to Centers for Disease Control and Prevention (CDC), chlamydia is a common STD that can cause infertility and a fatal ectopic pregnancy, a type of pregnancy that occurs outside the womb. The tough part is to determine if a person has chlamydia because for most people, symptoms do not show.
Nonetheless, some symptoms can be observed by infected patients. Women and men can experience abnormal discharge on their private parts and a burning sensation when urinating. The only way to prevent chlamydia at present is to not have vaginal, anal or oral sex at all. So this vaccine, if approved, is good news for those who are sexually active.
As per CDC statistics, almost a million and a half people in the United States were reported to have chlamydia in 2014. 433,325 are males, 1,006,441 are females and 2,023 are STD cases with unknown gender.
If you want to know more information about chlamydia and other STDs, you may contact American Sexual Health Association (ASHA) at 1-800-783-9877. Comment below your thoughts and follow Parent Herald for more news and updates.
